Form 4: Celularity Inc. Executive Haines Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
Senior Executive Vice President John R. Haines reports the vesting of restricted stock units (RSUs) and subsequent stock transactions.
Summary
- On February 17, 2025, John R. Haines, Senior Executive Vice President of Celularity Inc., reported transactions related to the vesting of 20,000 restricted stock units (RSUs) into Class A common stock.
- The vesting of these RSUs, initially granted on February 17, 2023, resulted in the acquisition of 20,000 shares of Class A common stock.
- Simultaneously, 7,035 shares were disposed of to cover tax withholding obligations at a price of $2.14 per share.
- Following these transactions, Haines directly owns 28,057 shares of Class A common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect changes in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 02/17/2023 | Reporting person was granted 20,000 RSUs |
| 02/17/2025 | RSUs vested and converted into Class A common stock; tax withholding occurred. |
| 02/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.